Stock RCKT ROCKET PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Rocket Pharmaceuticals, Inc.

Equities

RCKT

US77313F1066

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-24 EDT 		5-day change 1st Jan Change
21.42 USD -1.38% Intraday chart for Rocket Pharmaceuticals, Inc. -5.31% -28.53%
05-16 Transcript : Rocket Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
05-10 UBS Adjusts Rocket Pharmaceuticals Price Target to $51 From $54, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ROCKET PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
-1.38%-5.31%-28.53%-0.56%+27.73% 1.94B
Bearish
Bearish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. RCKT Stock
  4. Charts Rocket Pharmaceuticals, Inc.
  5. Comparison Chart